Monitoring of chemotherapy successfulness of platina/taxol chemotherapy protocol by using determination of serum urokinase plasminogen activator (uPA) and soluble urokinase plasminogen activator receptor (suPAR) in patients with ovarian carcinoma FI (Q42512376)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Monitoring of chemotherapy successfulness of platina/taxol chemotherapy protocol by using determination of serum urokinase plasminogen activator (uPA) and soluble urokinase plasminogen activator receptor (suPAR) in patients with ovarian carcinoma FI |
scientific article |
Statements
1 reference
Monitoring of chemotherapy successfulness of platina/taxol chemotherapy protocol by using determination of serum urokinase plasminogen activator (uPA) and soluble urokinase plasminogen activator receptor (suPAR) in patients with ovarian carcinoma FI (English)
1 reference
Dzenita Ljuca
1 reference
Zlatan Fatusić
1 reference
Ermina Iljazović
1 reference
Begzudin Ahmetović
1 reference
1 May 2007
1 reference
1 reference
7
1 reference
2
1 reference
111-116
1 reference
Identifiers
1 reference